Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 330.41M P/E - EPS this Y 100.00% Ern Qtrly Grth -
Income -82.67M Forward P/E -248.78 EPS next Y - 50D Avg Chg -14.00%
Sales 166.66M PEG - EPS past 5Y -43.92% 200D Avg Chg -20.00%
Dividend N/A Price/Book 1.19 EPS next 5Y 10.00% 52W High Chg -31.00%
Recommedations 1.70 Quick Ratio 3.50 Shares Outstanding 14.85M 52W Low Chg 4.00%
Insider Own 3.25% ROA -2.36% Shares Float 10.68M Beta 0.75
Inst Own 94.24% ROE -33.21% Shares Shorted/Prior 766.09K/572.32K Price 22.39
Gross Margin 62.30% Profit Margin -49.60% Avg. Volume 80,095 Target Price 30.33
Oper. Margin 56.80% Earnings Date May 7 Volume 88,467 Change -2.78%
About Anika Therapeutics Inc.

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.

Anika Therapeutics Inc. News
03/26/24 Has DexCom (DXCM) Outpaced Other Medical Stocks This Year?
03/16/24 Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2023 Earnings Call Transcript
03/15/24 Anika Therapeutics Full Year 2023 Earnings: EPS Misses Expectations
03/14/24 Q4 2023 Anika Therapeutics Inc Earnings Call
03/13/24 Anika Reports Fourth Quarter and Year-End 2023 Financial Results
03/08/24 Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:36 AM Sutro Biopharma, Inc. (STRO) Surges 9.5%: Is This an Indication of Further Gains?
02/27/24 Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
02/15/24 Stoke Therapeutics, Inc. (STOK) Stock Jumps 25.5%: Will It Continue to Soar?
02/14/24 Here's Why We're Not At All Concerned With Anika Therapeutics' (NASDAQ:ANIK) Cash Burn Situation
02/13/24 Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
01/18/24 Is There An Opportunity With Anika Therapeutics, Inc.'s (NASDAQ:ANIK) 50% Undervaluation?
12/14/23 New Strong Buy Stocks for December 14th
09:00 AM Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
11/07/23 Anika to Participate in Upcoming Investor Conferences
11/05/23 Anika Therapeutics, Inc. (NASDAQ:ANIK) Q3 2023 Earnings Call Transcript
11/03/23 Q3 2023 Anika Therapeutics Inc Earnings Call
11/02/23 Anika Therapeutics Inc (ANIK) Reports 3% Revenue Growth in Q3 2023, Raises Full-Year Guidance
11/02/23 Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business
10/23/23 Anika Therapeutics, Inc. (NASDAQ:ANIK) is favoured by institutional owners who hold 66% of the company
ANIK Chatroom

User Image Fullratio Posted - 1 week ago

$ANIK debt to equity is up by 30% since the previous quarter and by 30% year-on-year: https://fullratio.com/stocks/nasdaq-anik/anika-therapeutics

User Image DoubleDownDave Posted - 1 week ago

$ANIK Hidden truths A bone mineral density (BMD) test measures calcium and other minerals in bone. Bones containing more minerals are denser, so they tend to be stronger and less likely to break. Bones can become less dense as we age or if we develop certain medical conditions. When too much bone is lost, osteoporosis can develop. Effects of electromagnetic radiation exposure on bone mineral density, thyroid, and oxidative stress index in electrical workers. The longer people are prolonged to emf's the more important this company becomes. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758783/

User Image SexyStockSlayer Posted - 2 weeks ago

$ANIK the only bear here on the board lol

User Image YouOnlyLiveTwice Posted - 2 weeks ago

$ANIK Read carefully they have to cut the workforce to get profitable That means there’s NO growth… SELL or SHORT

User Image YouOnlyLiveTwice Posted - 2 weeks ago

$ANIK Train wreck company stay away Time to buy will be when Blanchard is gone ….

User Image YouOnlyLiveTwice Posted - 2 weeks ago

$ANIK This was once a company that made a lot of $$ when Sherwood and Silvia were running the company. Once they left I sold… Blanchard is an incompetent CEO. Just look at the numbers since she took over. I’m amazed how she still runs this company. They can’t make $$…..

User Image DonCorleone77 Posted - 2 weeks ago

$ANIK Anika Therapeutics to reduce 9% of workforce in cost reduction initiative In 2023, Anika launched multiple new products and made considerable progress addressing the new MDR regulatory requirements in Europe. With the progress made in 2023, and in recognition of the slower than expected pace of growth in some of its more mature product lines, the company has decided to further reduce its planned spending for 2024 and to reduce approximately 9% of its workforce, effective the end of the first quarter. The cost reductions, on an annualized basis, are expected to provide savings of approximately $10 million, excluding the impact of one-time costs.

User Image DonCorleone77 Posted - 2 weeks ago

$ANIK Anika Therapeutics sees FY24 revenue $168M-$173M, consensus $179.42M Sees FY24 adjusted EBITDA $25M-$30M. Blanchard continued, "We begin 2024 with renewed energy and strong momentum across the new products in our portfolio. Our HA-based Integrity Implant System is receiving very positive feedback, and its full market release is on track for mid-2024. We also remain focused on bringing Hyalofast and Cingal to the U.S. market. As we focus the business on our core strengths and highest value opportunities, we are confident that we will enhance value for shareholders."

User Image epsguid Posted - 2 weeks ago

$ANIK reported earnings of $0.05, consensus was ($0.15) via @eWhispers #epsbeat http://eps.sh/d/anik

User Image Stock_Titan Posted - 2 weeks ago

$ANIK Anika Reports Fourth Quarter and Year-End 2023 Financial Results https://www.stocktitan.net/news/ANIK/anika-reports-fourth-quarter-and-year-end-2023-financial-ehsyufy260pi.html

User Image AivelX Posted - 2 weeks ago

💡 #AivelX After-Hours Earnings Insights $ANIK - Ref.Earnings: 101 Next Day: 61% new high (max +24.3%) vs 19% new low (max -9.3%) 5 Days Later: 81% new highs, 36% new lows Same Week: 71% broke 27 (+4%) $CHRS - Ref.Earnings: 77 Next Day: 36% new high (max +30%) vs 48% new low (max -11.3%) 5 Days Later: 56% new highs, 66% new lows Same Week: All broke 2.5 (+5%) https://aivelx.com #AI #Insights

User Image AivelX Posted - 2 weeks ago

⚡️ Today 1 hour before the close we will share our latest Earnings Insights for the tickers below👇 After-Hours: $ANIK, $CHRS Tomorrow Premarket: $DG ✅ Early Access: https://aivelx.com #AivelX #AI #Insights

User Image Stock_Titan Posted - 2 weeks ago

$ANIK Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/ANIK/anika-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-j9echu2pi0so.html

User Image Stock_Titan Posted - 1 month ago

$ANIK Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024 https://www.stocktitan.net/news/ANIK/anika-to-issue-fourth-quarter-and-year-end-2023-financial-results-on-34l9lrxinhhy.html

User Image YouOnlyLiveTwice Posted - 1 month ago

$ANIK If you want to play in this sector looks at ESTA where they’re experiencing 20-30% growth per year as opposed to this which if they’re lucky 2-3%….

User Image Stock_Titan Posted - 1 month ago

$ANIK Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting https://www.stocktitan.net/news/ANIK/anika-highlights-its-recently-launched-integrity-implant-system-and-jx1rngeq6w8x.html

User Image VirmoMopire Posted - 01/30/24

$ANIK Looks like it is making some moves today! 📈

User Image cctranscripts Posted - 2 months ago

Statement of acquisition of beneficial ownership by individuals https://www.conferencecalltranscripts.org/summary/?id=12882997 $ANIK

User Image cctranscripts Posted - 2 months ago

Securities to be offered to employees in employee benefit plans, post-effective amendments https://www.conferencecalltranscripts.org/summary/?id=12882835 $ANIK

User Image risenhoover Posted - 2 months ago

$ANIK / Anika Therapeutics files form S-8 POS https://fintel.io/doc/sec-anika-therapeutics-inc-898437-s8-pos-2024-january-22-19744-2165?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image cctranscripts Posted - 2 months ago

Securities to be offered to employees in employee benefit plans https://www.conferencecalltranscripts.org/summary/?id=12880799 $ANIK

User Image risenhoover Posted - 2 months ago

$ANIK / Anika Therapeutics files S-8 registration statement (stock option plan) https://fintel.io/doc/sec-anika-therapeutics-inc-898437-s8-2024-january-19-19741-376?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image cctranscripts Posted - 2 months ago

SVP of Anika Therapeutics Inc. just declared owning 4,777 shares of Anika Therapeutics Inc. https://www.conferencecalltranscripts.org/summary/?id=12864193 $ANIK

User Image YouOnlyLiveTwice Posted - 2 months ago

$ANIK Looks like they will be NOT be profitable until 2025 …if that…. Company is a train wreck. Time to buy will be when they replace the current CEO

User Image tickeron Posted - 3 months ago

This is amazing! What do you think? $ANIK Stochastic Oscillator left the overbought zone. View odds of downtrend. https://srnk.us/go/4949128

User Image Aigner_Andreas Posted - 3 months ago

TD SELL $ANIK at 21.97, Supp 20.58 Resis 22.75 R11 HiLo 33% T1Y 36 buy 2.3 DIV N/A #Anika Ther #stocks #trading #finance #market

User Image StockAutomatePro Posted - 11/30/23

$ANIK Chart is suggesting a bullish trend for the stock. We alerted the BUY signal at $20.6 and we were able to close this one with profit at $22.31 📊 See more details at StockAutomate.com

User Image StockAutomatePro Posted - 11/29/23

$ANIK Chart is suggesting a bright future for the stock price. We alerted the BUY signal at $20.73 and we were able to close this one with profit at $22.11🤙 See more details at StockAutomate.com

User Image stockilluminati Posted - 4 months ago

$ANIK https://www.stockilluminati.com/anik/news.php - Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release

User Image Stock_Titan Posted - 4 months ago

$ANIK Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release https://www.stocktitan.net/news/ANIK/anika-announces-first-surgeries-performed-using-the-integrity-9ig2i4dq2rwg.html

Analyst Ratings
Barrington Research Outperform Mar 14, 24
Stephens & Co. Equal-Weight Mar 14, 24
Barrington Research Outperform Jan 3, 24
Barrington Research Outperform Nov 3, 23
Barrington Research Outperform Aug 14, 23
Stephens & Co. Equal-Weight Aug 10, 23
Stephens & Co. Equal-Weight May 31, 23
Stephens & Co. Equal-Weight Apr 14, 23
Barrington Research Market Perform Mar 7, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Colleran David EVP, General Counsel.. EVP, General Counsel, Corp Sec May 11 Buy 21.37 1,500 32,055 9,867 05/12/22
Colleran David EVP, General Counsel.. EVP, General Counsel, Corp Sec Mar 14 Buy 26.652 1,500 39,978 8,367 03/16/22
Blanchard Cheryl R President, CEO, Dire.. President, CEO, Director Mar 11 Buy 25.59 8,100 207,279 59,992 03/14/22
Levitz Michael L EVP, CFO, Treasurer EVP, CFO, Treasurer Mar 11 Buy 24.619 4,000 98,476 15,924 03/14/22